Use of methylnaltrexone for the treatment of opioid induced constipation & gastroIntestinal stasis in intensive care patients
Phase of Trial: Phase IV
Latest Information Update: 04 Mar 2017
At a glance
- Drugs Methylnaltrexone bromide (Primary)
- Indications Constipation
- Focus Therapeutic Use
- Acronyms MOTION
- 01 Mar 2017 Status changed from active, no longer recruiting to completed.
- 01 Sep 2016 Status changed from recruiting to active, no longer recruiting.
- 10 Dec 2015 Accrual to date is 7% according to against United Kingdom Clinical Research Network record.